• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA损伤可诱导肿瘤微环境中的胶质细胞源性神经营养因子(GDNF)分泌,其旁分泌效应会促进前列腺癌的治疗抵抗。

DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.

作者信息

Huber Roland M, Lucas Jared M, Gomez-Sarosi Luis A, Coleman Ilsa, Zhao Song, Coleman Roger, Nelson Peter S

机构信息

Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

出版信息

Oncotarget. 2015 Feb 10;6(4):2134-47. doi: 10.18632/oncotarget.3040.

DOI:10.18632/oncotarget.3040
PMID:25575823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4385841/
Abstract

Though metastatic cancers often initially respond to genotoxic therapeutics, acquired resistance is common. In addition to cytotoxic effects on tumor cells, DNA damaging agents such as ionizing radiation and chemotherapy induce injury in benign cells of the tumor microenvironment resulting in the production of paracrine-acting factors capable of promoting tumor resistance phenotypes. In studies designed to characterize the responses of prostate and bone stromal cells to genotoxic stress, we found that transcripts encoding glial cell line-derived neurotrophic factor (GDNF) increased several fold following exposures to cytotoxic agents including radiation, the topoisomerase inhibitor mitoxantrone and the microtubule poison docetaxel. Fibroblast GDNF exerted paracrine effects toward prostate cancer cells resulting in enhanced tumor cell proliferation and invasion, and these effects were concordant with the expression of known GDNF receptors GFRA1 and RET. Exposure to GDNF also induced tumor cell resistance to mitoxantrone and docetaxel chemotherapy. Together, these findings support an important role for tumor microenvironment damage responses in modulating treatment resistance and identify the GDNF signaling pathway as a potential target for improving responses to conventional genotoxic therapeutics.

摘要

尽管转移性癌症通常最初会对基因毒性疗法产生反应,但获得性耐药很常见。除了对肿瘤细胞的细胞毒性作用外,诸如电离辐射和化疗等DNA损伤剂会在肿瘤微环境的良性细胞中诱导损伤,从而导致能够促进肿瘤耐药表型的旁分泌作用因子的产生。在旨在表征前列腺和骨基质细胞对基因毒性应激反应的研究中,我们发现,在暴露于包括辐射、拓扑异构酶抑制剂米托蒽醌和微管毒物多西他赛在内的细胞毒性剂后,编码胶质细胞源性神经营养因子(GDNF)的转录本增加了几倍。成纤维细胞GDNF对前列腺癌细胞发挥旁分泌作用,导致肿瘤细胞增殖和侵袭增强,并且这些作用与已知的GDNF受体GFRA1和RET的表达一致。暴露于GDNF还会诱导肿瘤细胞对米托蒽醌和多西他赛化疗产生耐药性。总之,这些发现支持肿瘤微环境损伤反应在调节治疗耐药性中的重要作用,并确定GDNF信号通路是改善对传统基因毒性疗法反应的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/a0f619a33c12/oncotarget-06-2134-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/224b59a8a1ee/oncotarget-06-2134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/5f2e83afeb7c/oncotarget-06-2134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/b59d1c62b62c/oncotarget-06-2134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/6b37c12298fe/oncotarget-06-2134-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/fc1879187400/oncotarget-06-2134-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/a0f619a33c12/oncotarget-06-2134-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/224b59a8a1ee/oncotarget-06-2134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/5f2e83afeb7c/oncotarget-06-2134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/b59d1c62b62c/oncotarget-06-2134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/6b37c12298fe/oncotarget-06-2134-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/fc1879187400/oncotarget-06-2134-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e70/4385841/a0f619a33c12/oncotarget-06-2134-g006.jpg

相似文献

1
DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.DNA损伤可诱导肿瘤微环境中的胶质细胞源性神经营养因子(GDNF)分泌,其旁分泌效应会促进前列腺癌的治疗抵抗。
Oncotarget. 2015 Feb 10;6(4):2134-47. doi: 10.18632/oncotarget.3040.
2
DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes.DNA损伤在静止的肿瘤微环境中诱导一种分泌程序,促进不良癌症表型。
Mol Cancer Res. 2017 Jul;15(7):842-851. doi: 10.1158/1541-7786.MCR-16-0387. Epub 2017 Mar 29.
3
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.GDNF-RET 信号在 ER 阳性乳腺癌中是对芳香化酶抑制剂的反应和耐药的关键决定因素。
Cancer Res. 2013 Jun 15;73(12):3783-95. doi: 10.1158/0008-5472.CAN-12-4265. Epub 2013 May 6.
4
Effect of brefelamide on proliferation of 1321N1 human astrocytoma cells induced by glial cell line-derived neurotrophic factor.布雷非拉胺对胶质细胞源性神经营养因子诱导的1321N1人星形细胞瘤细胞增殖的影响。
Pharmazie. 2018 Jan 2;73(1):22-28. doi: 10.1691/ph.2018.7786.
5
GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.GFRA1:一种用于预防骨肉瘤化疗耐药性的新型分子靶标。
Int J Mol Sci. 2018 Apr 4;19(4):1078. doi: 10.3390/ijms19041078.
6
GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.GDNF/GFRA1 信号通路促进胶质母细胞瘤的化疗和放疗抵抗。
Sci Rep. 2024 Jul 31;14(1):17639. doi: 10.1038/s41598-024-68626-x.
7
Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells.胶质细胞源性神经营养因子影响成骨细胞的增殖。
Cytokine. 2012 Feb;57(2):276-81. doi: 10.1016/j.cyto.2011.10.023. Epub 2011 Dec 3.
8
A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer.胶质细胞源性神经营养因子在炎性细胞因子诱导表达及RET/GFRα1受体上调中在乳腺癌中的作用。
Cancer Res. 2007 Dec 15;67(24):11732-41. doi: 10.1158/0008-5472.CAN-07-2343.
9
The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.G691S RET基因多态性通过放大丝裂原活化蛋白激酶信号传导增加胶质细胞源性神经营养因子诱导的胰腺癌细胞侵袭。
Cancer Res. 2005 Dec 15;65(24):11536-44. doi: 10.1158/0008-5472.CAN-05-2843.
10
Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.SREBP抑制剂单独或与多西他赛联合使用对携带p53突变的前列腺癌的抗癌疗效。
Oncotarget. 2015 Dec 1;6(38):41018-32. doi: 10.18632/oncotarget.5879.

引用本文的文献

1
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer.转移性去势抵抗性前列腺癌的循环前列腺癌蛋白质组图谱及预后生物标志物
Clin Proteomics. 2025 Apr 18;22(1):13. doi: 10.1186/s12014-025-09536-6.
2
Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity.化疗诱导的富含半胱氨酸蛋白 61 降低急性 B 淋巴细胞白血病的化疗敏感性。
J Cancer Res Clin Oncol. 2024 Mar 26;150(3):159. doi: 10.1007/s00432-024-05692-8.
3
The contribution of the nervous system in the cancer progression.

本文引用的文献

1
Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?应用新型药物治疗去势抵抗性前列腺癌:已知情况与需求有哪些?
BJU Int. 2015 Mar;115(3):364-72. doi: 10.1111/bju.12736. Epub 2014 Jul 15.
2
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
3
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
神经系统在癌症进展中的作用。
BMB Rep. 2024 Apr;57(4):167-175. doi: 10.5483/BMBRep.2024-0019.
4
Nanomedicine Strategies for Targeting Tumor Stroma.靶向肿瘤基质的纳米医学策略
Cancers (Basel). 2023 Aug 17;15(16):4145. doi: 10.3390/cancers15164145.
5
Unveiling the Neural Environment in Cancer: Exploring the Role of Neural Circuit Players and Potential Therapeutic Strategies.揭示癌症中的神经环境:探索神经回路参与者的作用及潜在治疗策略。
Cells. 2023 Aug 3;12(15):1996. doi: 10.3390/cells12151996.
6
A network map of GDNF/RET signaling pathway in physiological and pathological conditions.生理和病理条件下GDNF/RET信号通路的网络图。
J Cell Commun Signal. 2023 Sep;17(3):1089-1095. doi: 10.1007/s12079-023-00726-1. Epub 2023 Jan 30.
7
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy.癌症相关成纤维细胞:致瘤性及癌症治疗靶点
Cancers (Basel). 2022 Aug 12;14(16):3906. doi: 10.3390/cancers14163906.
8
RET signaling pathway and RET inhibitors in human cancer.人类癌症中的RET信号通路与RET抑制剂
Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022.
9
Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells.间充质干/基质细胞可能通过诱导癌细胞对化疗产生抗性而降低癌症治疗的成功率。
Cancers (Basel). 2022 Aug 2;14(15):3761. doi: 10.3390/cancers14153761.
10
Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B.血清胶质细胞源性神经营养因子(sGDNF)是预测慢性乙型肝炎患者肝硬化的新型生物标志物。
Can J Gastroenterol Hepatol. 2022 Jul 9;2022:1048104. doi: 10.1155/2022/1048104. eCollection 2022.
EAU 前列腺癌指南。第 1 部分:筛查、诊断和以治愈为目的的局部治疗——2013 年更新。
Eur Urol. 2014 Jan;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046. Epub 2013 Oct 6.
4
Autonomic nerve development contributes to prostate cancer progression.自主神经发育促进前列腺癌的进展。
Science. 2013 Jul 12;341(6142):1236361. doi: 10.1126/science.1236361.
5
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.雄激素剥夺治疗后的前列腺癌进展:去势抵抗的机制和新的治疗方法。
Oncogene. 2013 Dec 5;32(49):5501-11. doi: 10.1038/onc.2013.206. Epub 2013 Jun 10.
6
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.治疗诱导的肿瘤微环境损伤通过 WNT16B 促进前列腺癌治疗抵抗。
Nat Med. 2012 Sep;18(9):1359-68. doi: 10.1038/nm.2890.
7
Towards a knowledge-based Human Protein Atlas.迈向基于知识的人类蛋白质图谱。
Nat Biotechnol. 2010 Dec;28(12):1248-50. doi: 10.1038/nbt1210-1248.
8
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.视网膜母细胞瘤肿瘤抑制因子控制雄激素信号和人前列腺癌的进展。
J Clin Invest. 2010 Dec;120(12):4478-92. doi: 10.1172/JCI44239. Epub 2010 Nov 22.
9
DNA damage-mediated induction of a chemoresistant niche.DNA 损伤介导的耐药生态位诱导。
Cell. 2010 Oct 29;143(3):355-66. doi: 10.1016/j.cell.2010.09.043.
10
Global gene expression analysis of reactive stroma in prostate cancer.前列腺癌中反应性基质的全基因表达分析
Clin Cancer Res. 2009 Jun 15;15(12):3979-89. doi: 10.1158/1078-0432.CCR-08-1899. Epub 2009 Jun 9.